Enanta Pharmaceuticals
ENTA
#7360
Rank
HK$3.45 B
Marketcap
HK$119.74
Share price
5.92%
Change (1 day)
163.38%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.68 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are HK$1.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30HK$1.92 B0.2%
2023-09-30HK$1.92 B352.97%
2022-09-30HK$0.42 B38.51%
2021-09-30HK$0.30 B29.44%
2020-09-30HK$0.23 B10.5%
2019-09-30HK$0.21 B33.21%
2018-09-30HK$0.16 B-17.49%
2017-09-30HK$0.19 B121.62%
2016-09-30HK$87.96 M15.16%
2015-09-30HK$76.37 M45.5%
2014-09-30HK$52.49 M4.05%
2013-09-30HK$50.44 M-20.97%
2012-09-30HK$63.83 M97.81%
2011-09-30HK$32.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
HK$1.062 T 63,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.40 B 52,460.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$58.69 B 3,392.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$604.07 B 35,841.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.13 B 36,142.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.57 B 28,850.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland